The Jaide Health platform provides AI-assisted language support for routine verbal exchanges and written translations commonly used throughout the healthcare process. These include intake-related communications, discharge information, and other administrative interactions where language barriers can create delays for patients and healthcare staff. According to AMN, human interpreters will continue to be used when conversations require greater clinical accuracy, empathy, and patient-safety considerations. The acquisition is intended to address communication gaps that often arise outside physician consultations and acute-care settings.

“This is an important strategic move in AMN’s ongoing mission to improve access to care for all,” said Cary Grace, President and CEO of AMN Healthcare. “By expanding language support across more moments in the healthcare journey, we can help health systems deliver a more seamless experience for patients and care teams while continuing to rely on the critical expertise of our qualified interpreters when it matters most.”

The Jaide Health solution is already in use with clients operating across multiple healthcare environments, where it has been applied to patient communications and workflow support. AMN stated that the technology has demonstrated value in real-world healthcare settings and will now become part of its broader language services offering. As part of the transaction, the Jaide Health team will join AMN Healthcare.

“We believe we’ve built one of the strongest solutions in the market, and joining AMN Language Services lets us reach more patients through AMN’s scale and clinical-quality standards,” said Joe Corkery, MD, CEO and co-founder of Jaide Health. “AMN was our first choice because of our shared commitment to quality. Together, we can pair smart AI assistance with the high standards of AMN’s human interpreting to provide LEP patients with a voice outside of clinical encounters, which we know leads to better outcomes and experiences.”

Financial terms of the deal were not disclosed. The AMN Healthcare Acquires Jaide Health transaction expands language support capabilities across the patient journey, while the AMN Healthcare Acquires Jaide Health announcement also reinforces the continued importance of human interpreters in healthcare communications.

The decision follows findings that equated the daily time savings to roughly five weeks per staff member each year. Health Innovation and Safety Minister Preet Kaur Gill said: “Every day, doctors, nurses and other healthcare professionals spend valuable time on administrative tasks that take them away from patients.” She added: “By rolling out Microsoft Copilot across the NHS, we can reduce that burden, free up clinicians’ time and help staff focus on what they do best, caring for patients.” Rob Thompson, Chief Digital, Data and Technology Officer at NHS England, said: “The potential to save clinical staff nearly a day’s worth of admin time every fortnight could be a gamechanger for patients.” He added: “We’re making sure every pound is spent on cutting waiting times and boosting care through the Plan for Change and 10 Year Health Plan.”

The deployment will support a range of operational and administrative functions across NHS England. Ward clerks will use the technology for patient discharge processes, rota planning and bed management, while medical secretaries will apply it to meeting documentation and template creation. Administrative teams in HR, finance and procurement will also use the platform, and management groups will employ it to prepare board papers and briefings. NHS England will additionally gain access to Copilot Studio, enabling individual NHS Trusts to build customized AI agents for workflow automation, including support for helpdesk operations, complaints handling, freedom of information requests and financial processing. Agent 365 will provide governance controls to ensure those agents comply with organizational security requirements.

Microsoft UK and Ireland CEO Darren Hardman said: “By rolling out Microsoft 365 Copilot at scale, NHS teams can cut through everyday admin and spend more time where it matters most.” He added: “Bringing AI safely into the flow of healthcare will help ease pressures, improve productivity, and support better decision-making across the health service.” NHS England serves approximately 56 million people and employs around 1.4 million staff, making this one of the largest enterprise AI deployments undertaken by a healthcare organization. The structured onboarding programme will run for 12 months and is intended to support adoption across the health system while providing a large-scale example of AI implementation in public healthcare.

Under the terms of the agreement, clients operating within corporate health trusts, private medical insurance claims environments, and NHS-commissioned care settings will gain access to a comprehensive analysis of their historic claims data. The objective is to ensure these organisations are receiving genuine value for money through a rigorous examination of how resources are being deployed. Using machine learning and medical expertise, the solution retrospectively analyses medical treatment data alongside insurer-approved treatment plans to identify where waste can be minimised and resources maximised making this a meaningful advancement in healthcare claims intelligence.

Neil Atkinson, Mercer Marsh Benefits UK Strategic Healthcare Consulting Leader, underlined the urgency behind the collaboration: “Healthcare organisations are under increasing pressure to improve outcomes while managing costs and complexity. Together, Marsh and Kirontech will help clients spend their resources effectively and ensure people are being treated appropriately. This agreement means we can accelerate our strategy to positively impact societal healthcare.”

Omar Chebli, Chief Executive Officer of Kirontech, highlighted the untapped potential within organisations’ existing data: “Healthcare organisations are sitting on data that could transform how they manage risk and allocate resources, but turning that into confident, board-level decisions requires the right expertise alongside the right technology. Collaborating with Marsh means we can bring that full picture to a much wider range of organisations, faster. Together, we are giving leadership teams the clarity to act and the confidence that their money is being spent where it matters most.”

The partnership between Marsh and Kirontech positions healthcare claims intelligence as a critical lever for organisations seeking to align clinical outcomes with financial accountability ensuring that both patient welfare and institutional resources are managed with greater precision and confidence.

The issue? Most people have no clue where to begin and when already overwhelmed, the last thing needed is any more foggy chaos.

Here’s the good news…

Searching for top notch mental health counseling services can be easy. By utilizing the following tips a therapist that is a great fit can be found quicker than most imagine.

What’s Inside:

1. Why So Many People Struggle to Find the Right Therapist
2. What to Look for in Mental Health Counseling Services
3. The Different Types of Mental Health Professionals
4. How to Narrow Down Your Options
5. Red Flags to Watch Out For
6. Questions to Ask Before You Commit

Why So Many People Struggle to Find the Right Therapist

That gap exists for one big reason: most people don’t know how to start.

Navigating the mental health system can be difficult. There are so many professional degrees, types of therapy, and ways to treat someone – it can be overwhelming, especially when help is needed.

Knowing what to look for when getting the right help is half the battle. After that everything else is easy.

What to Look for in Mental Health Counseling Services

Not all mental health counseling services are created equal.

Research has proven time and time again that the therapeutic alliance directly affects outcomes. The rapport between client and therapist is one of the strongest predictors of positive treatment results. Fit really does matter.

When searching for mental health counseling services, three factors matter most:

• Specialisation: What is the therapist’s track record with the problem being faced? Anxiety? Depression? Trauma? Relationship issues?
• Treatment style: How do they approach therapy? CBT? DBT? EMDR? Chatting? Some styles resonate better with certain folks.
• Accessibility: Is it easy to get to their office? Do they provide evenings or weekend hours? Do they offer Telehealth visits?

Accessibility is more important than most realise. Over half of all therapy appointments are now conducted online or over the phone, widening access to mental health resources to those who hadn’t previously had it readily available.

If distance is an issue, providers such as Wellness Hills New Jersey Mental Health Treatment provide complete mental health counseling services that help quality care become accessible.

The Different Types of Mental Health Professionals

Only 1 in 7 U.S. adults received mental health treatment by a counselor or therapist over the last year – even though mental illness is one of the most common health conditions Americans face today.

This is where a lot of people get confused…

Mental health professionals fall into many categories, each with their own specific job. Learning about how they differ helps narrow the search.

Here’s a quick breakdown:

• Psychiatrists – Medical doctors who can diagnose mental health conditions and prescribe medication.
• Psychologists – Doctoral-level providers who focus on evaluation and therapy, but often can’t prescribe.
• Licensed Professional Counselors (LPCs) – Master’s level therapists that offer talk therapy and counseling for various problems.
• Licensed Clinical Social Workers (LCSWs) – Trained in therapy, but can also help clients access more comprehensive services and support resources.
• Marriage and Family Therapists (MFTs) – Specialists in relationship and family dynamics.

One is not inherently better than another. The most important factors are whether they have experience in the area of concern and whether there is simply a good click.

How to Narrow Down Your Options

So how do you actually find the right person?

Start here:

Step 1 – Get clear on goals. What does success look like? Managing anxiety? Working through past trauma? Improving a relationship? Just needing a space to process things? Knowing what is wanted makes it much easier to weed through options.

Step 2 – Confirm insurance and budget. Treatment is an investment. Make sure the therapist accepts the relevant insurance plan or has sliding-scale fees before getting too far down the path. Many great therapists do not take insurance – ask if they provide a superbill for reimbursement.

Step 3 – Search an established directory. Psychology Today, SAMHSA’s treatment locator, and directories from professional associations are all good places to begin. Most allow filtering by specialty, location, insurance accepted, and types of therapy provided.

Step 4 – Book a consultation. Most therapists will provide a free 15–20 minute introductory call. Take it. Notice how it feels to talk to them and if they seem sincerely interested. If it doesn’t feel right – continue the search.

Red Flags to Watch Out For

Therapists are people too. Here are some red flags to watch out for.

Watch out for:

• A therapist who does most of the talking and rarely asks questions
• Vague or dismissive responses to questions about their qualifications or approach
• No clear explanation of what the treatment plan will look like
• Pressure to commit to long-term packages upfront
• A lack of any real follow-through between sessions

A competent therapist will lay out expectations early on what to expect in the process, how success will be tracked, and how course corrections will be handled if results aren’t coming through.

Questions to Ask Before Committing

Here are the questions worth asking during an initial consultation:

• What is your experience treating [specific issue]?
• What therapy approaches do you use?
• How do you measure progress in treatment?
• What does a typical session look like?
• What’s your cancellation policy?
• Do you offer telehealth sessions?

These questions are not meant to be challenging. They are meant to help with the decision. Any reputable mental health counseling services provider will be happy to answer them.

The Bottom Line

It takes some work to find the right therapist, but it will be worth it.

Finding the right fit really does matter. Sessions become something to look forward to rather than dread. Progress happens at a quicker pace. Mental health, relationships and quality of life all have room for dramatic change.

To quickly recap:

• Get clear on goals before starting the search
• Understand the different types of mental health professionals
• Use a reputable directory and check insurance
• Always book a consultation first
• Ask the right questions before committing
• Trust the gut – if it doesn’t feel right, keep looking

Mental health matters just as much as physical health. Finding the right support can take time. It’s not laziness – it’s one of the best investments anyone can make.

According to information released by Indiana Governor Mike Braun’s office, the Boston Scientific investment is valued at $138 million. The company plans to build and equip a 500,000-square-foot facility within Plainfield Innovation Park. Once operational, the site is expected to reinforce and expand the company’s U.S.-based logistics and distribution network while supporting broader global operations.

The planned facility will incorporate advanced technology along with light manufacturing capabilities. Boston Scientific said the site will include the processes and operational infrastructure required to meet regulatory compliance requirements. Upon completion, the center will assume responsibility for the global distribution of the company’s medical devices, making it a key component of its supply chain and logistics framework.

Construction is scheduled to begin later this year. Commenting on the announcement, Braun said: “Indiana’s commitment to further advancing our already robust life sciences sector continues to pay dividends as we welcome Boston Scientific to Plainfield. This new facility can bolster the state’s global leadership in life sciences and medical device innovation while creating hundreds of high-skilled, high-wage jobs, providing more opportunities for Hoosiers to advance their skills, grow their careers and provide for their families.” The Boston Scientific project is expected to further strengthen Indiana’s position as a hub for life sciences and medical device operations.

The Argos system operates through a patient’s existing arterial line and uses a single reusable cable to connect with a radial blood pressure transducer. According to the companies, the monitor requires no calibration and features a multi-touch screen interface that can be operational within minutes. Training can be completed in less than five minutes, while the system eliminates the need for expensive disposable accessories. The expansion follows Medtronic’s continued efforts to enhance its Acute Care & Monitoring portfolio through additional patient-monitoring technologies.

A key feature of the Argos platform is its Multi-Beat Analysis (MBA) algorithm, developed by researchers at the Massachusetts Institute of Technology (MIT) and Michigan State University. Rather than evaluating one heartbeat at a time, MBA analyzes multiple heartbeats from the blood pressure signal, enabling direct modelling of a patient’s vascular resistance. Medtronic states that the system delivers accurate hemodynamic information across 10 parameters and maintains performance during variations in vasomotor tone, low cardiac output conditions and arrhythmias.

Commenting on the expansion, Marc DeMartini, Western Europe commercial VP of the ACM business at Medtronic, said: “Our focus is on helping clinicians navigate complexity with greater clarity. The Argos cardiac output monitor adds meaningful haemodynamic insight to our Acute Care & Monitoring portfolio and complements established technologies such as INVOS cerebral oximetry, supporting a more comprehensive view of patient status across perioperative and critical care environments. By bringing this technology to Western Europe, we are reinforcing our commitment to partner with healthcare systems as they work to deliver high-quality care in an increasingly resource-constrained environment.”

Marc Zemel, CEO of Retia Medical, added: “Medtronic is an ideal partner for Retia Medical as we expand access to the Argos cardiac output monitor in Western Europe. With a robust portfolio, deep customer relationships, and leadership in advancing acute care and monitoring technologies, Medtronic is uniquely positioned to help bring the benefits of our innovative solution to clinicians and patients across Western Europe. We look forward to working together to help to set a new standard in hemodynamic monitoring.” The Medtronic Distribution Deal marks the latest step in expanding the availability of the Argos platform in the region.

According to an official statement released by Egypt’s Ministry of Health and Population, Minister Abdel Ghaffar reaffirmed Egypt’s commitment to strengthening its healthcare partnership with Mauritania through the exchange of expertise, capacity-building initiatives, and technical support spanning a wide range of medical fields. Ministry spokesperson Hossam Abdel Ghaffar confirmed that the discussions reviewed progress on existing cooperation programmes and assessed opportunities for expanding collaboration in professional training, skills development, and specialised consultancy services.

A notable outcome of the meeting was the focus on pharmaceutical collaboration between the two countries. Abdel Ghaffar directed ministry officials to organise a dedicated visit for the Mauritanian delegation to the Arab Company for Drug Industries and Medical Appliances (ACDIMA), providing them first-hand exposure to Egypt’s pharmaceutical manufacturing capabilities and regulatory framework. This move is seen as a direct step toward enabling Mauritania to benefit from Egypt’s established pharmaceutical infrastructure.

The meeting also covered preventive healthcare, with both sides examining how Mauritania could draw on Egypt’s experience in disease prevention, public health management, and healthcare system governance.

Medical tourism featured prominently as another area of focus in the Egypt-Mauritania healthcare discussions. Both delegations reviewed practical mechanisms to facilitate the treatment of Mauritanian patients in Egyptian hospitals and specialised medical centres. Beyond patient referrals, the two sides explored the possibility of deploying Egyptian cardiologists to hospitals in Mauritania, a step aimed at building local medical capacity and enabling the transfer of specialised expertise directly to Mauritanian healthcare facilities.

Ambassador Ould Sidi Abdallah expressed appreciation for Egypt’s continued support to Mauritania, commending the progress achieved by Egypt’s healthcare sector and acknowledging its role in supporting Arab and African nations through medical cooperation and expertise-sharing initiatives.

The meeting brought together a senior cross-ministerial delegation on the Egyptian side, including Deputy Minister of Health Amr Kandil, Adviser to the Minister for International Health Relations Mohamed Gad, Director-General of International Health Relations Susan Zanaty, and officials from the Mauritanian Embassy in Cairo. The breadth of representation underscored the significance both governments place on advancing this healthcare partnership.

The Egypt-Mauritania healthcare discussions align with Egypt’s wider strategy of expanding healthcare partnerships across Africa and the Arab world, with particular emphasis on medical training, pharmaceutical production, healthcare services delivery, and technical cooperation with partner nations.

According to the two organisations, the healthcare AI model will integrate Mayo Clinic’s anonymised health data, medical knowledge base and patient care experience with Microsoft’s technology infrastructure. Once operational at scale, the model is expected to analyse diverse types of clinical information to support tasks such as earlier diagnosis and more personalised treatment planning.

The model is currently being deployed within Mayo Clinic’s own clinical environment, where it will be tested and refined through real-world application. The organisations have not disclosed how widely the model is being used at this stage, which specific clinical areas are involved, or when it might be made available to other healthcare providers beyond Mayo Clinic.

Ownership of the model will rest with Mayo Clinic, while Microsoft intends to make it accessible to developers and healthcare companies through Azure Foundry APIs software tools that allow external parties to connect the model directly into their own applications and services.

Gianrico Farrugia, M.D., president and CEO of Mayo Clinic, commented on the development: “We have long believed AI can help transform healthcare. Seven years ago, we launched Mayo Clinic Platform to move healthcare from a pipeline to a platform model through a safe, trusted, patient-centric de-identified data foundation designed to accelerate innovation, breakthroughs, and cures. Now, by combining our clinical expertise and data foundation with Microsoft’s engineering and AI capabilities, we are once again building something new in healthcare and bringing more of Mayo Clinic to more patients.”

Mustafa Suleyman, CEO of Microsoft AI, also spoke on the collaboration: “This is the best collaboration imaginable to help us accelerate towards that future. Mayo has unparalleled clinical expertise, de-identified clinical health data and longitudinal medical insights, and we’re thrilled to partner with their world-class physicians to build a state-of-the-art foundation model for healthcare.”

Healthcare has emerged as one of the most active frontiers for advanced artificial intelligence development, though it also presents considerable challenges. Medical AI systems must be capable of handling complex clinical data, accommodating individual patient health histories, and satisfying the most rigorous standards for safety, privacy and validation.

Under the European Union’s AI Act, AI-based software developed for medical purposes is classified as high-risk. This classification requires that such systems meet a defined set of safeguards, including risk-mitigation mechanisms, high-quality training datasets, clear communication to users, and ongoing human oversight, as outlined by the European Commission.

The growing use of AI in healthcare is reflected in broader public behaviour as well. A 2025 survey of 2,000 patients in the United Kingdom, conducted by healthcare startup Semble, found that one in four representing 24% of respondents were turning to AI tools and social media platforms such as ChatGPT and Instagram for health-related guidance. Separately, in Denmark, visits to the public health information website Patienthåndbogen dropped by 31% between January and November 2025 following the launch of Google’s AI Overview, according to the country’s national news agency Ritzau.

Healthcare AI model development is gaining momentum because the technology holds the potential to process large volumes of medical information rapidly, assist clinicians in diagnostics and complex clinical decisions, and significantly reduce the administrative burden on healthcare staff. Microsoft has described “frontier medical intelligence” as being close to realisation, positioning this partnership as a step in that direction.

Nevertheless, the application of artificial intelligence in medicine continues to raise legitimate concerns around accuracy, potential bias, data privacy and accountability. These concerns are particularly prominent given the sensitive nature of health data and the direct impact that clinical decisions can have on patient outcomes. The two organisations have not provided a detailed timeline for when the healthcare AI model will be made available to healthcare providers outside of Mayo Clinic’s own clinical setting.

Among the newly cleared capabilities is Auto Measure Abdomen, an AI-enabled feature developed to automate routine measurement tasks during examinations. Philips said the technology can help reduce variability in measurements while saving time for clinicians. The company also expanded access to Koios AI decision-support tools, which were previously available off-cart. The functionality is now integrated directly into EPIQ Elite and Affiniti systems, allowing clinicians to classify breast lesions and thyroid nodules within the ultrasound workflow. According to Philips, integration with Koios Bi-RADS enables interpretation and malignancy risk assessment in less than two seconds.

The Elevate Plus package also introduces imaging upgrades aimed at improving visualization of anatomy and blood flow. Philips said XRes Pro+ provides cleaner tissue detail and sharper anatomical boundaries, helping create more consistent images across different body types. In addition, Super Res MVI Pro enhances visualization of microvascular flow, giving clinicians greater clarity when assessing blood circulation and vascular structures. These enhancements are designed to improve image quality while supporting more efficient diagnostic workflows.

Commenting on the clearance, Jie Xue, chief business leader, Precision Diagnosis, Philips, said: “Elevate Plus underscores our commitment to advancing AI-powered ultrasound to help clinicians deliver more consistent, efficient, and confident ultrasound care to patients. By combining intelligent imaging with AI-powered workflow automation across our ultrasound platform, Elevate Plus is designed to reduce variability, streamline routine exams, and support faster, more informed clinical decisions as care teams face growing demand.”

Gretchen Sammy, ultrasound manager at Boston Medical Center, stated: “Elevate Plus is a game-changer for our ultrasound workflow. Automating key measurement tasks allows our sonographers to reduce scanning time by up to 30% without sacrificing clinical precision. During our evaluation, measurements were consistently placed exactly where we would expect them saving time while maintaining the accuracy we rely on.”

Maria Cristina Chammas, director of ultrasound at Hospital das Clínicas, School of Medicine, University of São Paulo, added that AI Ultrasound automation could help shorten scanning times, improve workflow efficiency and reduce repetitive manual tasks that contribute to sonographer fatigue while supporting more consistent clinical results.

The updated LEAF Platform features a redesigned wearable sensor that is smaller, more comfortable, and easier for patients to use at home. The system enables care teams to remotely monitor patient progress by collecting data on physical activity and rehabilitation adherence during the recovery period. The platform is intended to give clinicians meaningful, real-time visibility into how patients are recovering after procedures such as total knee and total hip replacements.

According to Smith+Nephew, the next-generation system includes improvements in sensor design and connectivity, making it more practical for widespread clinical use. The company indicated that the LEAF Platform is part of its broader digital and robotics strategy, which is focused on delivering connected care solutions that bridge the gap between surgical procedures and long-term patient outcomes. Remote patient monitoring through wearable sensor technology has increasingly become a priority for healthcare providers seeking to manage patient recovery more efficiently while reducing unnecessary clinical visits.

Smith+Nephew stated that the LEAF Platform launch aligns with growing demand among healthcare systems for scalable digital tools that extend the reach of clinical care teams. The platform is designed to integrate into existing care workflows, allowing providers to act on recovery data without disrupting established protocols. With the next-generation LEAF Platform now available, Smith+Nephew reinforces its position in the expanding remote patient monitoring market, where wearable sensor adoption continues to gain traction across orthopaedic and rehabilitation settings.